SECURITIES AND EXCHANGE COMMISSION

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________



FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

________________
 


Date of Report (Date of earliest event reported):
July 31, 2007

Alpharma Inc.
 

(Exact name of registrant as specified in its charter)
 

Delaware
(State or other jurisdiction of incorporation)

1-8593
(Commission File
Number)

22-2095212
(IRS Employer Identification)
 

440 Route 22, Bridgewater, New Jersey 08807
(Address of principal executive offices) (Zip Code)
 

Registrant's telephone number, including area code
(866) 322-2525
 
 

Not Applicable

(Former name or former address, if changed since

last report)

 

Item 2.02. Results of Operations and Financial Condition

On July 31, 2007, Alpharma Inc. issued a press release announcing its financial results for the quarter ended June 30, 2007. A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statement and Exhibits

(c) Exhibits.

    1. Press release issued by Alpharma Inc. on July 31, 2007.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 

ALPHARMA INC.

By: /s/ Thomas J. Spellman III
 

Thomas J. Spellman III
Executive Vice President, Chief Legal Officer & Corporate Secretary

Date: August 1, 2007